Literature DB >> 14577914

Lentivector-mediated transfer of Bmi-1 and telomerase in muscle satellite cells yields a duchenne myoblast cell line with long-term genotypic and phenotypic stability.

Christophe Cudré-Mauroux1, Teresa Occhiodoro, Stéphane König, Patrick Salmon, Laurent Bernheim, Didier Trono.   

Abstract

Conditionally immortalized human cells are valuable substrates for basic biologic studies, as well as for the production of specific proteins and for the creation of bioartificial organs. We previously demonstrated that the lentivector-mediated transduction of immortalizing genes into human primary cells is an efficient method for obtaining such cell lines. Here, we used human muscle satellite cells as model targets to examine the impact of the transduced genes on the genotypic and phenotypic characteristics of the immortalized cells. The most commonly used immortalizing gene, the SV40 large T antigen (T-Ag), was extremely efficient at inducing the continuous growth of primary myoblasts, but the resulting cells rapidly accumulated major chromosomal aberrations and exhibited profound phenotypic changes. In contrast, the constitutive expression of telomerase and Bmi-1 in satellite cells from a control individual and from a patient suffering from Duchenne's muscular dystrophy yielded cell lines that remained diploid and conserved their growth factor dependence for proliferation. However, despite the absence of detectable cytogenetic abnormalities, clones derived from satellite cells of a control individual exhibited a differentiation block in vitro. In contrast, a Duchenne-derived cell line exhibited all the phenotypic characteristics of its primary parent, including an ability to differentiate fully into myotubes when placed in proper culture conditions. This cell line should constitute a useful reagent for a wide range of studies aimed at this disease.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14577914     DOI: 10.1089/104303403322495034

Source DB:  PubMed          Journal:  Hum Gene Ther        ISSN: 1043-0342            Impact factor:   5.695


  37 in total

1.  Adenoviral vector DNA for accurate genome editing with engineered nucleases.

Authors:  Maarten Holkers; Ignazio Maggio; Sara F D Henriques; Josephine M Janssen; Toni Cathomen; Manuel A F V Gonçalves
Journal:  Nat Methods       Date:  2014-08-24       Impact factor: 28.547

Review 2.  Islet transplantation: current status and future directions.

Authors:  Betul Hatipoglu; Enrico Benedetti; José Oberholzer
Journal:  Curr Diab Rep       Date:  2005-08       Impact factor: 4.810

3.  Accumulation of senescent cells in mitotic tissue of aging primates.

Authors:  Jessie C Jeyapalan; Mark Ferreira; John M Sedivy; Utz Herbig
Journal:  Mech Ageing Dev       Date:  2006-11-20       Impact factor: 5.432

4.  Regulation of episomal gene expression by KRAB/KAP1-mediated histone modifications.

Authors:  Isabelle Barde; Elisa Laurenti; Sonia Verp; Anna Claire Groner; Christopher Towne; Viviane Padrun; Patrick Aebischer; Andreas Trumpp; Didier Trono
Journal:  J Virol       Date:  2009-03-11       Impact factor: 5.103

5.  Histone deacetylase inhibition rescues gene knockout levels achieved with integrase-defective lentiviral vectors encoding zinc-finger nucleases.

Authors:  Laetitia P L Pelascini; Ignazio Maggio; Jin Liu; Maarten Holkers; Toni Cathomen; Manuel A F V Gonçalves
Journal:  Hum Gene Ther Methods       Date:  2013-10-29       Impact factor: 2.396

6.  Histone deacetylase inhibition activates transgene expression from integration-defective lentiviral vectors in dividing and non-dividing cells.

Authors:  Laetitia P L Pelascini; Josephine M Janssen; Manuel A F V Gonçalves
Journal:  Hum Gene Ther       Date:  2012-12-11       Impact factor: 5.695

Review 7.  Gene therapy in large animal models of muscular dystrophy.

Authors:  Zejing Wang; Jeffrey S Chamberlain; Stephen J Tapscott; Rainer Storb
Journal:  ILAR J       Date:  2009

8.  Rapid and sensitive lentivirus vector-based conditional gene expression assay to monitor and quantify cell fusion activity.

Authors:  Manuel A F V Gonçalves; Josephine M Janssen; Maarten Holkers; Antoine A F de Vries
Journal:  PLoS One       Date:  2010-06-03       Impact factor: 3.240

9.  Prevention of senescence progression in reversibly immortalized human ensheathing glia permits their survival after deimmortalization.

Authors:  Vega García-Escudero; Ana García-Gómez; Ricardo Gargini; María J Martín-Bermejo; Elena Langa; Justo G de Yébenes; Alicia Delicado; Jesús Avila; María T Moreno-Flores; Filip Lim
Journal:  Mol Ther       Date:  2009-11-24       Impact factor: 11.454

10.  Controllable expansion of primary cardiomyocytes by reversible immortalization.

Authors:  Yue Zhang; Edem Nuglozeh; Fatouma Touré; Ann Marie Schmidt; Gordana Vunjak-Novakovic
Journal:  Hum Gene Ther       Date:  2009-12       Impact factor: 5.695

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.